Drupal.behaviors.print = function(context) {window.print();window.close();}>
Claiming Breach of Agreement, Rosetta Genomics Ending Licensing Deal with Avatao
June 13, 2012
Claiming Breach of Agreement, Rosetta Genomics Ending Licensing Deal with Avatao
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Rosetta Genomics Terminates Deal with Avatao
July 17, 2012 / GenomeWeb Daily News
Rosetta Genomics, Prime Health Reach Deal for Coverage of MiRview Mets2 Assay
May 20, 2013 / GenomeWeb Daily News
Rosetta, Precision Therapeutics Reach Co-marketing Deal for miRview mets2 Assay
July 24, 2012 / GenomeWeb Daily News
Rosetta Genomics Restructures, Eliminating 35 Positions
October 11, 2011 / GenomeWeb Daily News
Rosetta Genomics Granted US Patent for miRNA Used in Diagnostic Tests
May 12, 2011 / Gene Silencing News